drugset / Trial / NCT03063606
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
Phase 2/3
Completed
31 enrolled
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will test the effectiveness of cognitive-behavioral therapy as a specialist treatment for binge eating disorder (BED) in patients with obesity. This is a controlled test of whether, amongst non-responders to acute treatments, cognitive-behavioral therapy augments on-going blinded pharmacotherapy (either naltrexone/bupropion or placebo), compared with no additional behavioral treatment .
Timeline
- Start
- 2017-09-05
- Primary completion
- 2021-12-01
- Completion
- 2022-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bupropion | Small molecule | — | — |
| Background | Naltrexone | Small molecule | — | — |